Screener
Revolution Medicines, Inc. RVMD Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan
Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept rvmd:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan.
The source filing: Revolution Medicines, Inc.’s 10-K, filed February 25, 2026. Open the filing →
- Filed
- Feb 25, 2026, 4:11 PM EST
- Fiscal year
- FY2025
- Accession
- 0001193125-26-071563
FAQ
- What is Revolution Medicines, Inc.'s proceeds from issuance of common stock under employee stock purchase plan?
- Revolution Medicines, Inc. (RVMD) reported proceeds from issuance of common stock under employee stock purchase plan of $3.39M in Q4 2025.
- How has Revolution Medicines, Inc.'s proceeds from issuance of common stock under employee stock purchase plan changed year-over-year?
- Revolution Medicines, Inc.'s proceeds from issuance of common stock under employee stock purchase plan increased by 81.9% year-over-year, from $1.87M to $3.39M.
- What does proceeds from issuance of common stock under employee stock purchase plan mean?
- Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan as reported by Revolution Medicines, Inc. Common Stock.
Ask your AI about Revolution Medicines, Inc.'s proceeds from issuance of common stock under employee stock purchase plan.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude